Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional)

About this opportunity

The goal of this Funding Opportunity Announcement (FOA) is to encourage applications for studies that will enhance knowledge of mechanisms associated with neuropsychiatric symptoms (NPS) in persons with Alzheimer's disease (AD) or Alzheimer's disease-related dementias (ADRD). The findings are expected to advance mechanistic understanding of both biobehavioral and neurobiological pathways leading to NPS. Findings may also provide insight into novel therapeutic targets that can be advanced into interventions to treat and prevent the development of NPS in AD and/or ADRD. This R01 grant mechanism supports investigator-initiated research projects and may optionally include clinical trials.

research Alzheimer's disease dementia neuropsychiatric symptoms mental health research aging neurobiological pathways biobehavioral mechanisms therapeutic targets ADRD

Who can apply

Applicant Types

organization

Organization Types

academic, nonprofit, for profit, government, tribal

Project Locations

🇺🇸 United States

Region

United States

How to apply

Stages

1 single_stage

External listing — not managed by a verified Grantory funder

External Application

This opportunity requires you to apply directly on the funder's website.

Apply on External Site

AI-Extracted Data

This opportunity was automatically extracted from an external source using AI. Details such as amounts, closing dates, and eligibility may be incomplete or inaccurate.

Always verify on the official source

Similar opportunities

Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional)

Great match

This funding opportunity announcement encourages applications for studies that will enhance knowledg...

Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)

Great match

The purpose of this Notice of Funding Opportunity (NOFO) is to invite applications that bundle indep...

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

Great match

The goal of this Notice of Funding Opportunity (NOFO) is to provide funding support for the pre-clin...

Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed)

Great match

This Notice of Funding Opportunity (NOFO) encourages research on the biology of high-confidence risk...